Clearview Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Clearview Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-51	Closed	-$28K	–	638
2022 Q2	$28K	Hold	51	–	–	0.02%	240
2022 Q1	$30K	Sell	51 -65	-56%	-$37.3K	0.02%	250
2021 Q4	$77K	Hold	116	–	–	0.05%	189
2021 Q3	$66K	Hold	116	–	–	0.04%	209
2021 Q2	$59K	Hold	116	–	–	0.04%	226
2021 Q1	$53K	Hold	116	–	–	0.03%	221
2020 Q4	$54K	Buy	+116	New	+$54.4K	0.04%	192

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearview Wealth Advisors's TMO Position: Q3 2022 in Review

Clearview Wealth Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2022, closing a stake of 51 shares — an estimated $28K sold.

Clearview Wealth Advisors first reported a position in TMO in Q4 2020 and held it in 7 quarters. The position peaked at $77K in Q4 2021. 2,268 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

Clearview Wealth Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2022 after selling out during the quarter.
Clearview Wealth Advisors sold 51 Thermo Fisher Scientific shares in Q3 2022, an estimated $28K.
Clearview Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 7 quarters.
Clearview Wealth Advisors's Thermo Fisher Scientific position peaked at $77K in Q4 2021.
2,268 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Clearview Wealth Advisors's 13F filing for Q3 2022, filed 18 Oct 2022.